Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects

被引:52
作者
Hatsuda, Sawako [1 ]
Shoji, Tetsuo [1 ]
Shinohara, Kayo [1 ]
Kimoto, Eiji [1 ]
Mori, Katsuhito [1 ]
Fukumoto, Shinya [1 ]
Koyama, Hidenori [1 ]
Emoto, Masanori [1 ]
Nishizawa, Yoshiki [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Dept Metabol Endocrinol & Mol Med, Abeno Ku, Osaka 5458585, Japan
关键词
atherosclerosis; angiopoietin-like protein 3; risk factor; ultrasonography;
D O I
10.1159/000098153
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Angiopoietin-like protein 3 (ANGPTL3) is a liverderived plasma protein that modulates plasma triglyceride clearance, angiogenesis and atherosclerosis in experimental models. So far, no study has examined its role in atherosclerosis in human subjects. We evaluated the possible association between plasma ANGPTL3 level and carotid artery intima-media thickness (CA-IMT) and femoral artery intima-media thickness (FA-IMT) in healthy human subjects. Methods: The subjects were 381 healthy volunteers. Plasma ANGPTL3 was determined by a specific ELISA. CA-IMT and FA-IMT were measured by high-resolution B-mode ultrasonography. Results: The plasma ANGPTL3 level was 764 8 291 ng/ml (mean +/- SD). CA-IMT showed a significant positive correlation with plasma ANGPTL3 and other classical risk factors such as age, blood pressure, and plasma glucose and lipid levels. The positive association between ANGPTL3 and CA-IMT remained significant after adjustment for age, sex, smoking, body mass index, systolic blood pressure, plasma glucose, insulin resistance index, triglyceride, and high-density and low-density lipoprotein cholesterol levels. ANGPTL3 also showed a positive association with FA-IMT independent of these factors. Conclusions: These results demonstrate for the first time that ANGPTL3 is closely associated with arterial wall thickness in human subjects. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 24 条
[1]   A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice [J].
Ando, Y ;
Shimizugawa, T ;
Takeshita, S ;
Ono, M ;
Shimamura, M ;
Koishi, R ;
Furukawa, H .
JOURNAL OF LIPID RESEARCH, 2003, 44 (06) :1216-1223
[2]   VEGF-A, VEGF-D and VEGF-DΔNΔC induced intimal hyperplasia in carotid arteries [J].
Bhardwaj, S ;
Roy, H ;
Heikura, T ;
Ylä-Herttuala, S .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (11) :669-676
[3]   ANGPTL3 stimulates endothelial cell adhesion and migration via integrin αvβ3 and induces blood vessel formation in vivo [J].
Camenisch, G ;
Pisabarro, MT ;
Sherman, D ;
Kowalski, J ;
Nagel, M ;
Hass, P ;
Xie, MH ;
Gurney, A ;
Bodary, S ;
Liang, XH ;
Clark, K ;
Beresini, M ;
Ferrara, N ;
Gerber, HP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) :17281-17290
[4]   Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas [J].
Emoto, M ;
Nishizawa, Y ;
Maekawa, K ;
Hiura, Y ;
Kanda, H ;
Kawagishi, T ;
Shoji, T ;
Okuno, Y ;
Morii, H .
DIABETES CARE, 1999, 22 (05) :818-822
[5]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[6]   Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population [J].
Fukumoto, M ;
Shoji, T ;
Emoto, M ;
Kawagishi, T ;
Okuno, Y ;
Nishizawa, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (03) :703-707
[7]   Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method [J].
Hirano, T ;
Ito, Y ;
Koba, S ;
Toyoda, M ;
Ikejiri, A ;
Saegusa, H ;
Yamazaki, J ;
Yoshino, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) :558-563
[8]   Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients [J].
Hosoi, M ;
Nishizawa, Y ;
Kogawa, K ;
Kawagishi, T ;
Konishi, T ;
Maekawa, K ;
Emoto, M ;
Fukumoto, S ;
Shioi, A ;
Shoji, T ;
Inaba, M ;
Okuno, Y ;
Morii, H .
CIRCULATION, 1996, 94 (04) :704-707
[9]   PURIFICATION AND CHARACTERIZATION OF LIPOPROTEIN-LIPASE AND HEPATIC TRIGLYCERIDE LIPASE FROM HUMAN POSTHEPARIN PLASMA - PRODUCTION OF MONOSPECIFIC ANTIBODY TO THE INDIVIDUAL LIPASE [J].
IKEDA, Y ;
TAKAGI, A ;
YAMAMOTO, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1003 (03) :254-269
[10]   HIGH-RESOLUTION B-MODE ULTRASONOGRAPHY IN EVALUATION OF ATHEROSCLEROSIS IN UREMIA [J].
KAWAGISHI, T ;
NISHIZAWA, Y ;
KONISHI, T ;
KAWASAKI, K ;
EMOTO, M ;
SHOJI, T ;
TABATA, T ;
INOUE, T ;
MORII, H .
KIDNEY INTERNATIONAL, 1995, 48 (03) :820-826